Sanofi's Tolebrutinib Earns FDA Breakthrough Designation for Non-Relapsing Secondary Progressive MS
CompanyDrug

Sanofi’s Tolebrutinib Earns FDA Breakthrough Designation for Non-Relapsing Secondary Progressive MS

Roche's cobas 6800/8800 Systems 2.0 Earn CE Certification, Set for US Market Entry
CompanyMedical Device

Roche’s cobas 6800/8800 Systems 2.0 Earn CE Certification, Set for US Market Entry

ARS Pharmaceuticals' Neffy Receives Market Filings in Asia-Pacific Region
CompanyDrug

ARS Pharmaceuticals’ Neffy Receives Market Filings in Asia-Pacific Region

Fujian Cosunter Pharmaceutical's GST-HG141 Earns Breakthrough Designation for Chronic Hepatitis B
CompanyDrug

Fujian Cosunter Pharmaceutical’s GST-HG141 Earns Breakthrough Designation for Chronic Hepatitis B

Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress
Policy / Regulatory

Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress

Quantum Hi-Tech (ChemPartner) Plans to Raise Over RMB 930 Million in Private Placement
CompanyDeals

Quantum Hi-Tech (ChemPartner) Plans to Raise Over RMB 930 Million in Private Placement

AbbVie Acquires Roche's Nimble Therapeutics to Boost Immunology Pipeline
CompanyDeals

AbbVie Acquires Roche’s Nimble Therapeutics to Boost Immunology Pipeline

iFlytek's Xunfei Healthcare Passes HKEX Hearing for AI-Powered Medical IPO
CompanyDeals

iFlytek’s Xunfei Healthcare Passes HKEX Hearing for AI-Powered Medical IPO

Innovent Biologics Partners with Eli Lilly for Distribution of Jaypirca in China
CompanyDeals

Innovent Biologics Partners with Eli Lilly for Distribution of Jaypirca in China

Accropeutics Gets FDA Green Light for Phase II UC Study of RIPK2 Inhibitor AC-101
CompanyDrug

Accropeutics Gets FDA Green Light for Phase II UC Study of RIPK2 Inhibitor AC-101

EMA's CHMP Supports Approval of Eli Lilly's Omvoh (Mirikizumab) for Crohn's Disease
CompanyDrug

EMA’s CHMP Supports Approval of Eli Lilly’s Omvoh (Mirikizumab) for Crohn’s Disease

Wepon Medical's WP107 for Myasthenia Gravis Accepted for FDA Review
CompanyDrug

Wepon Medical’s WP107 for Myasthenia Gravis Accepted for FDA Review